Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Clinical Model topic
No spam. Unsubscribe anytime.
Task force outlines clinical model and safety recommendations: preparation, supervised medicine sessions and integration
Summary
Members recommended that psychedelic-assisted care follow a three-part clinical model (preparation, supervised medicine sessions, integration); emphasized trauma-informed training, cultural responsiveness and limits on unsupervised home use. MAPS ethics and phase‑3 trial approaches were discussed as precedents.
Members of the Alaska Psychedelic Policy Task Force described a clinical model and a set of best practices they consider important for patient safety if psychedelic medicines become medically available.
Dr. DeMolina summarized a three-part model used in trials and contemporary practice: preparation sessions, supervised medicine sessions in a controlled setting, and post‑session integration therapy. “It’s psychedelic assisted psychotherapy, not psychotherapy assisted psychedelics,” Dr. DeMolina said, arguing the therapy component is central to outcomes reported in phase‑3 trials.
The task force discussed concrete elements of that model: multiple preparation sessions (one to three depending on medication), an informed consent process with detailed safety planning, medical and clinical evaluation to rule out exclusionary conditions (cardiac risks, bipolar disorder considerations), and mandatory integration sessions. Dr. Lindquist recommended wording in the draft change “psychological evaluation” to “medical and clinical evaluation” to better reflect the range of assessment tools clinicians may use; the task force agreed to revise language accordingly.
On sitters and facilitators, members debated whether two-person teams should be required for medicine sessions, as in some MAPS protocols, and whether nonlicensed facilitators could operate independently. Dr. DeMolina described the practical benefits of two clinicians during long sessions but noted insurance and CPT‑coding limits for multi‑hour, two‑person staffing. Several members supported ongoing clinical supervision for nonlicensed facilitators and attachment to a certified clinic or provider network; Dr. Lindquist said she would expect facilitators to have “ongoing clinical supervision” and not to practice entirely independently.
Cultural and traditional-healer roles were also discussed. Task force members proposed pathways for traditional healing practitioners modeled on existing Alaska Commission on Behavioral Health Certification approaches, while stressing that traditional healers would be part of multidisciplinary teams with patient consent rather than mandatory for every patient. Participants emphasized telehealth and local “boots-on-the-ground” roles (behavioral health aides or trained facilitators) as ways to extend access to remote communities while maintaining safety.
Ending: The task force agreed to convert much of the operational detail into a descriptive section of the draft report that explains current best practices and to label the credential matrix as an example for further development rather than adopting it immediately.
